Uniformity of glycyl bridge lengths in the mature cell walls of fem mutants of methicillin-resistant Staphylococcus aureus

Journal of Bacteriology

Volumn 195, Issue 7, 2013, Pages 1421-1427

  Sharif, Shasad ^a   Kim, Sung Joon ^b   Labischinski, Harald ^c   Chen, Jiawei ^a   Schaefer, Jacob ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b BAYLOR UNIVERSITY   (United States)

^c MerLion Pharmaceuticals GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCINE;

ARTICLE; BACTERIAL CELL WALL; CELL DIVISION; CELL MATURATION; CHEMICAL STRUCTURE; CROSS LINKING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY;

BACTERIAL PROTEINS; CELL WALL; GENE KNOCKOUT TECHNIQUES; GLYCINE; MAGNETIC RESONANCE SPECTROSCOPY; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OLIGOPEPTIDES; PEPTIDOGLYCAN;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 84875538266     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.01471-12     Document Type: Article

References (31)

1. Hakenbeck R, Coyette J. 1998. Resistant penicillin-binding proteins. Cell. Mol. Life Sci. 54:332-340.
2. Labischinski H. 1992. Consequences of the interaction of β-lactam antibiotics with penicillin-binding proteins from sensitive and resistant Staphylococcus aureus strains. Med. Microbiol. Immunol. 181:241-265.
3. Kim SJ, Cegelski L, Stueber D, Singh M, Dietrich E, Tanaka KSE, Parr TR, Jr, Far AR, Schaefer J. 2008. Oritavancin exhibits dual mode of action to inhibit cell wall biosynthesis in Staphylococcus aureus. J. Mol. Biol. 377: 281-293.
4. Kim SJ, Matsuoka S, Patti GJ, Schaefer J. 2008. Vancomycin derivative with damaged D-Ala-D-Ala binding cleft binds to cross-linked peptidoglycan in the cell wall of Staphylococcus aureus. Biochemistry 47:3822- 3831.
5. Kim SJ, Schaefer J. 2008. Hydrophobic side-chain length determines activity and conformational heterogeneity of a vancomycin derivative bound to the cell wall of Staphylococcus aureus. Biochemistry 47:10155- 10161.
6. Kern T, Hediger S, Mueller P, Giustini C, Joris B, Bougault C, Vollmer W, Simorre J-P. 2008. Toward the characterization of peptidoglycan structure and protein-peptidoglycan interactions by solid-state NMR spectroscopy. J. Am. Chem. Soc. 130:5618 -5619.
7. Dmitriev BA, Toukach FV, Schaper K-J, Holst O, Rietschel ETT, Ehlers S. 2003. Tertiary structure of bacterial murein: the scaffold model. J. Bacteriol. 185:3458 -3468.
8. Seligman SJ, Pincus MR. 1987. A model for the three-dimensional structure of peptidoglycan in staphylococci. J. Theor. Biol. 124:275-292.
9. Berger-Bächi B, Tschierske M. 1998. Role of Fem factors in methicillin resistance. Drug Resist. Updat. 1:325-335.
10. Rohrer S, Berger-Bächi B. 2003. FemABX peptidyl transferases: a link between branched-chain cell wall peptide formation and β-lactam resistance in gram-positive cocci. Antimicrob. Agents Chemother. 47:837- 846.
11. Schneider T, Senn MM, Berger-Baechi B, Tossi A, Sahl H-G, Wiedemann I. 2004. In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus. Mol. Microbiol. 53:675- 685.
12. de Lencastre H, Jonge BLM, Matthews PR, Tomasz A. 1994. Molecular aspects of methicillin resistance in Staphylococcus aureus. J. Antimicrob. Chemother. 33:7-14.
13. Rohrer S, Ehlert K, Tschierske M, Labischinski H, Berger-Bächi B. 1999. The essential Staphylococcus aureus gene fmhB is involved in the first step of peptidoglycan pentaglycine interpeptide formation. Proc. Natl. Acad. Sci. U. S. A. 96:9351-9356.
14. Labischinski H, Ehlert K, Berger-Bächi B. 1998. The targeting of factors necessary for expression of methicillin resistance in staphylococci. J. Antimicrob. Chemother. 41:581-584.
15. Henze U, Sidow T, Wecke J, Labischinski H, Berger-Bächi B. 1993. Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureus. J. Bacteriol. 175:1612-1620.
16. Ehlert K, Schröder W, Labischinski H. 1997. Specificities of FemA and FemB for different glycine residues: FemB cannot substitute for FemA in staphylococcal peptidoglycan pentaglycine side chain formation. J. Bacteriol. 179:7573-7576.
17. Kopp U, Roos M, Wecke J, Labischinski H. 1996. Staphylococcal peptidoglycan interpeptide bridge biosynthesis: a novel antistaphylococcal target? Microb. Drug Resist. 2:29-41.
18. Berger-Bächi B. 1983. Insertional inactivation of staphylococcal methicillin resistance by Tn551. J. Bacteriol. 154:479-487.
19. Berger-Bächi B, Kohler ML. 1983. A novel site on the chromosome of Staphylococcus aureus influencing the level of methicillin resistance: genetic mapping. FEMS Microbiol. Lett. 20:305-309.
20. Hübscher J, Jansen A, Kotte O, Schäfer J, Majcherczyk PA, Harris LG, Bierbaum G, Heinemann M, Berger-Bächi B. 2007. Living with an imperfect cell wall: compensation of femAB inactivation in Staphylococcus aureus. BMC Genomics 8:307. doi:10.1186/1471-2164-8-307.
21. Strandén AM, Ehlert K, Labischinski H, Berger-Bächi B. 1997. Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus. J. Bacteriol. 179:9 -16.
22. Ling B, Berger-Bächi B. 1998. Increased overall antibiotic susceptibility in Staphylococcus aureus femAB null mutants. Antimicrob. Agents Chemother. 42:936 -938.
23. Billot-Klein D, Shlaes D, Bryant D, Bell D, van Heijenoort J, Gutmann L. 1996. Peptidoglycan structure of Enterococcus faecium expressing vancomycin resistance of the VanB type. Biochem. J. 313:711-715.
24. Giesbrecht P, Kersten T, Maidhof H, Wecke J. 1998. Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin. Microbiol. Mol. Biol. Rev. 62:1371-1414.
25. Sharif S, Kim SJ, Labischinski H, Schaefer J. 2009. Characterization of peptidoglycan in Fem-deletion mutants of methicillin-resistant Staphylococcus aureus by solid-state NMR. Biochemistry 48:3100 -3108.
26. Sharif S, Singh M, Kim SJ, Schaefer J. 2009. Staphylococcus aureus peptidoglycan tertiary structure from carbon-13 spin diffusion. J. Am. Chem. Soc. 131:7023-7030.
27. Tong G, Pan Y, Dong H, Pryor R, Wilson GE, Schaefer J. 1997. Structure and dynamics of pentaglycyl bridges in the cell walls of Staphylococcus aureus by 13C-15N REDOR NMR. Biochemistry 36:9859 -9866.
28. Gullion T, Schaefer J. 1989. Detection of weak heteronuclear dipolar coupling by rotational-echo double-resonance nuclear magnetic resonance. Adv. Magn. Reson. 13:57- 83.
29. Hing AW, Vega S, Schaefer J. 1992. Transferred-echo double-resonance NMR. J. Magn. Reson. A 96:205-209.
30. Hing AW, Vega S, Schaefer J. 1993. Measurement of heteronuclear dipolar coupling by transferred-echo double-resonance NMR. J. Magn. Reson. A 103:151-162.
31. Patti GJ, Chen J, Gross ML. 2009. Method revealing bacterial cell-wall architecture by time-dependent isotope labeling and quantitative liquid chromatography/mass spectrometry. Anal. Chem. 81:2437-2445.